| 2025 | Rapamycin Modulates the Polarisation of CD4+T Cells Towards TH1 Cells in Patients with Active Granulomatosis with Polyangiitis and Microscopic Polyangiitis
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Plasma Exchange as an Adjunctive Therapeutic Option for Severe and Refractory Antineutrophil Cytoplasmic Antibody-Negative Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| MEDICINA-LITHUANIA |
| 2025 | Utility of serum cystatin C measured at diagnosis in evaluating cross-sectional activity and predicting all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL RHEUMATOLOGY |
| 2025 | Lower Myeloperoxidase-ANCA Titres at Diagnosis Are Associated with End-Stage Kidney Disease Progression During Follow-Up in Rituximab-Treated Patients with Microscopic Polyangiitis | MEDICINA-LITHUANIA |
| 2025 | Development of a new scoring system for predicting recurrent thrombosis in patients with antiphospholipid syndrome | ADVANCES IN RHEUMATOLOGY |
| 2025 | Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohort
| SEMINARS IN ARTHRITIS AND RHEUMATISM |
| 2025 | A new formula consisting of the five-factor score and earliest vasculitis damage index at diagnosis for predicting poor outcomes of antineutrophil cytoplasmic antibody-associated vasculitis
| FRONTIERS IN MEDICINE |
| 2025 | Impact of Early MPO-ANCA Positivity on Unique Clinical Features in Korean Patients with EGPA: A Single-Centre Cohort Study
| MEDICINA-LITHUANIA |
| 2025 | Clinical Significance of Peripheral Arterial Disease Evaluation in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDICINA-LITHUANIA |
| 2025 | Serum Biomarkers of Pulmonary Damage and Risk for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease | JOURNAL OF RHEUMATOLOGY |
| 2025 | Overlap Syndrome of Primary Sjögren Syndrome with Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Based on the American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) Criteria
| DIAGNOSTICS |
| 2025 | Validation of the 2022 ACR/EULAR classification criteria for giant cell arteritis in Korean patients with giant cell arteritis | MODERN RHEUMATOLOGY |
| 2025 | Serum Wnt3A levels are significantly associated with cross-sectional vasculitis activity and end-stage kidney disease during follow-up of patients with antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2025 | Clinical Utility of Serum sCD200/sCD200R Ratios in Predicting Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Risk of Gout Among Patients With Tuberculosis: A Nationwide Cohort Study in South Korea
| INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES |
| 2025 | Remnant Cholesterol Levels at Diagnosis May Predict Acute Coronary Syndrome Occurrence During Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Incidence of systemic vasculitides after Mycobacterium tuberculosis infection: a population-based cohort study in Korea
| RHEUMATOLOGY |
| 2025 | Circulating GDF15 May Estimate Vasculitis Activity and Predict Poor Outcomes During the Disease Course of ANCA-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Serum glutathione peroxidase-3 concentration at diagnosis as a biomarker for assessing disease activity and damage of antineutrophil cytoplasmic antibody-associated vasculitis at diagnosis
| FRONTIERS IN MOLECULAR BIOSCIENCES |
| 2025 | Prediction potential of serum sulfatide levels at diagnosis for end-stage kidney disease progression in ANCA-associated vasculitis
| MEDICINE |
| 2025 | Reclassification of the overlap syndrome of Behçet’s disease and antineutrophil cytoplasmic antibody-associated vasculitis in patients with Behçet’s disease
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2024 | Serum Soluble Receptors for Advanced Glycation End-Products May Predict Mortality in Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| YONSEI MEDICAL JOURNAL |
| 2024 | Serum Glial Fibrillary Acidic Protein Can Predict Cross-Sectional Vasculitis Activity by Reflecting Renal Involvement in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDICINA-LITHUANIA |
| 2024 | Association between Mycobacterium tuberculosis infection and the risk of inflammatory arthritides | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2024 | Serum syndecan1 has the potential to reflect activity at diagnosis and predict death during follow-up in patients with ANCA-associated vasculitis
| ARTHRITIS RESEARCH & THERAPY |
| 2024 | Clinical Significance of Overlap Syndrome of Histologically Confirmed Lupus Nephritis with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2024 | Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria | MODERN RHEUMATOLOGY |
| 2024 | The monocyte-to-high-density lipoprotein-cholesterol ratio at diagnosis is associated with cerebrovascular accident during follow-up in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| Journal of Rheumatic Diseases |
| 2024 | Overlap syndrome of systemic sclerosis with antineutrophil cytoplasmic antibody-associated vasculitis according to 2022 ACR/EULAR criteria
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2024 | Earliest total vascular damage index scores independently predict all-cause mortality in patients with ANCA-associated vasculitis | Clinical and Experimental Rheumatology |
| 2024 | Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis : Correlation with disease activity | ZEITSCHRIFT FUR RHEUMATOLOGIE |
| 2023 | Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis
| ARTHRITIS RESEARCH & THERAPY |
| 2023 | Prevalence, clinical significance, and persistence of autoantibodies in COVID-19
| VIROLOGY JOURNAL |
| 2023 | Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre Study
| JOURNAL OF CLINICAL MEDICINE |
| 2023 | Acute Brain Infarction in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Korean Single-Center Study | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY |
| 2023 | Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2023 | Predictive potential of albumin-alkaline phosphatase ratio for cerebrovascular accident in patients with antineutrophil cytoplasmic antibody-associated vasculitis | ANNALS OF CLINICAL BIOCHEMISTRY |
| 2022 | BVAS version 3 and BVAS/GPA: standing on the same line? | CLINICAL RHEUMATOLOGY |
| 2022 | Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis
| ANNALS OF PALLIATIVE MEDICINE |
| 2022 | Nutrition Risk Index Score at Diagnosis Can Effectively Predict Poor Prognosis in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | JOURNAL OF RENAL NUTRITION |
| 2022 | Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study
| JOURNAL OF IMMUNOLOGY RESEARCH |
| 2022 | Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander? | RHEUMATOLOGY |
| 2021 | Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
